FAQ’s

VesCell is unique as the only stem cell therapy focused on regenerating blood vessels to address conditions like angina, ischemic congestive heart failure, peripheral arterial disease (PAD), critical limb ischemia (CLI), and vascular dementia. Unlike traditional treatments that manage symptoms, VesCell targets the root cause by restoring circulation. Clinical trials with 318 subjects have shown it improves cardiac function, saves limbs from amputation, and even reverses early vascular dementia symptoms for over a decade in some cases, offering hope where other treatments fall short.

VesCell has been tested in seven clinical trials with 498 subjects, showing no serious adverse events. As an autologous therapy, it uses your own stem cells, minimizing risks like rejection or allergic reactions. Mild, temporary side effects, such as discomfort at the injection site, may occur. Our Board Certified Physicians monitor each patient closely to ensure safety throughout the process.

The VesCell treatment process is streamlined and typically takes 7-10 days:

• Day 1: Blood is drawn to extract your stem cells.
• Days 2-7: Your stem cells are processed and expanded in our state-of-the-art facility.
• Day 7-10: VesCell is administered via injection by a qualified physician.
• Follow-Up: Regular check-ins with our team include progress tracking using tools like the MCI Screen for cognitive function.
  Patients often see gradual improvements over weeks to months, with significant benefits possible within the first year.

VesCell treats a range of conditions, including:

• Angina
• Ischemic congestive heart failure
• Peripheral arterial disease (PAD)
• Critical limb ischemia (CLI)
• Vascular dementia

It works by using your own stem cells to regenerate blood vessels, restoring circulation to damaged areas in the brain, heart, and limbs, addressing the root cause of these conditions.

VesCell is backed by over 20 years of clinical research, including seven trials with 498 subjects, demonstrating safety and efficacy. Unlike experimental therapies, VesCell has a robust clinical track record, with real-world success stories like a patient maintaining reversed vascular dementia symptoms for over 10 years. As an autologous therapy (using your own stem cells), it minimizes risks like rejection. Our pursuit of FDA approval further ensures VesCell meets the highest standards of safety and reliability.

VesCell Treatment Satisfaction Guarantee Offered by Hemostemix Inc.

At Hemostemix, we are committed to providing innovative cell therapy options to patients who have exhausted conventional treatment. While individual responses to VesCell (ACP-01) therapy may vary, we stand behind the science and our commitment to your care.

✅ Satisfaction Guarantee

If, following treatment with VesCell, a patient does not experience any measurable clinical or functional improvement within the guaranteed period, and all criteria below are met, the patient may apply for a partial or full refund of the treatment fee.

🔬 Scientific and Medical Parameters That Void the Guarantee

To ensure fairness and medical integrity, this guarantee is void if any of the following clinical parameters are met, indicating the treatment has produced a measurable response:

1. Clinical or Functional Improvement

At least one of the following outcomes is observed within 6 months post-treatment:

• Cardiac Conditions
  • ≥10% relative improvement in LVEF% (Left Ventricular Ejection Fraction) as measured by echocardiography, MRI, or MUGA.
  • ≥50-meter increase in 6-Minute Walk Test (6MWT) distance from baseline.
  • ≥10-point improvement in Minnesota Living with Heart Failure Questionnaire (MLHFQ) or equivalent.
• Peripheral Arterial Disease (PAD)
  • ≥30% increase in Ankle-Brachial Index (ABI).
  • Documented improved arterial perfusion on Doppler or angiogram.
  • ≥1-point decrease in Rutherford classification.
• Vascular Dementia
  • ≥3-point improvement in ADAS-Cog or ≥1-point in MMSE from baseline.
  • Functional improvement noted in clinician-verified activities of daily living (ADL) scale.

2. Noncompliance or External Factors

This guarantee is also void if:

• The patient does not follow post-treatment medical advice and monitoring protocols.
• The patient experiences a new unrelated medical condition that interferes with the interpretation of outcomes.
• The patient fails to attend follow-up assessments as outlined in the clinical protocol.

📝 Refund Request Procedure

Refund requests must be:

• Submitted in writing within 30 days after the 6-month post-treatment evaluation.
• Accompanied by baseline and follow-up diagnostic data collected through Hemostemix-approved facilities.
• Reviewed and confirmed by an independent medical board or ethics panel affiliated with Hemostemix.

Partial refunds may apply if any non-treatment-related expenses were incurred.

⚠️ Disclaimer

This guarantee does not constitute a promise of cure or specific medical outcome. Rather, it is a commitment to transparency, ethical conduct, and accountability in the delivery of VesCell therapy.

If you have a qualifying condition like angina, ischemic congestive heart failure, PAD, CLI, or vascular dementia, you may be eligible for our clinical trials or treatment under exemption. Contact us for a free consultation to discuss your condition, review your medical records, and determine eligibility. Participation in trials not only provides access to cutting-edge therapy but also contributes to advancing medical research.

The $37,000 price reflects the personalized nature of VesCell, the first and only stem cell therapy globally designed to grow blood vessels and restore damaged vascular areas in the brain, heart, and limbs. This cost covers:

• Advanced stem cell manufacturing tailored to each patient.
• Rigorous clinical oversight by our Board Certified Physicians.
• Comprehensive care, including access support, follow-ups, and diagnostic tracking.

We’ve designed flexible options to make VesCell accessible:

• 0% Interest Financing: Spread the $37,000 cost over:
  • 1-year term (12 months): $3,083.33 per month
  • 2-year term (24 months): $1,541.67 per month
  • 5-year term (60 months): $616.67 per month
• Cost Reduction Efforts: As we scale our manufacturing, we’re working to lower costs and will pass savings on to patients.
• Future Insurance Coverage: While VesCell is not yet covered by insurance, our pursuit of FDA approval may open reimbursement pathways in the future.